GlomCon Hawaii 2026
Advancing Glomerular Disease Care:
Education, Research, and Collaboration in Paradise
)%20(1).png)
Registration now open!
When: August 3 to August 7, 2026
Where: Hyatt Regency Maui, 200 Nohea Kai Dr., Lahina, HI 96761
GlomCon Hawaii is an annual hybrid conference dedicated to advancing education, research, and collaboration in nephrology. As part of the GlomCon Foundation’s mission, the meeting brings together clinicians, researchers, and experts from around the world to explore the latest developments in glomerular diseases, pathology, and treatment strategies.
Building on a strong legacy of virtual education, GlomCon Hawaii extends this work by creating opportunities for deeper engagement through interactive case discussions, pathology reviews, and evidence-based treatment panels. The conference offers a collaborative space for the nephrology community to connect, exchange ideas, and advance patient care.
Designed to combine scientific rigor with meaningful networking, GlomCon Hawaii creates opportunities for both emerging and experienced nephrologists to learn from thought leaders, contribute to important conversations shaping the field, and stay current with clinical and research advances.
Whether participating in person in Hawaii or joining virtually, GlomCon Hawaii connects a global community committed to improving kidney health and shaping the future of nephrology.
8:30 AM - 9:00 AM
Keynote Address
9:00 AM - 10:00 AM
IgA Nephropathy I : A case-based review
-
Risk prediction and early diagnosis
-
Biomarkers and disease monitoring
-
Pathogenesis and true disease modification
10:00 AM - 10:15 AM
Break
10:15 AM - 11:15 AM
IgA Nephropathy - Spoiled for Choice : A roundtable discussion
-
The Sequencing Problem: "What First?"
-
Maintenance strategy: "How Long?
-
Combination Therapy: "Mixing and Matching"
-
High-Risk and Rare Variants: “Crescents, Vasculitis, RPGN”
11:15 AM - 11:35 AM
Break + Live Expert Interview in Poster Hall
11:15 AM - 12:05 PM
Oral Abstract Presentation
12:05 PM - 12:20 PM
Break
12:20 PM - 1:15 PM
Exhibitor Spotlight
Lunch Talk2:30 PM - 2:45 PM
Break
1:15 PM - 1:30 PM
Poster Presentations
1:30 PM - 2:30 PM
Lupus Nephritis: A case-based review
-
The "Triple Therapy" Choice: "Obinutuzumab or Belimumab or Voclosporin?"
-
The Steroid-Free Holy Grail: "How Low Can We Go?"
-
The "Repeat Biopsy" Debate: "Protocol or PRN?"
-
The Anti-CD38 and CAR-T "Reset": "Is it a Cure or a Pause?"
2:30 PM - 2:45 PM
Break
2:45 PM - 3:45 PM
The Standard of Care
Presentation followed by panel discussion
Prevention and Management of Secondary: Complications in GN
-
anticoagulant and thrombosis
-
nosocomial infections
-
vaccinations
-
fertility
3:45 PM - 4:45 PM
Break
4:00 PM - 5:00 PM
Richard Glassock Endowed Lectureship
6:30 PM - 9:00 PM
Reception
-
8:30 AM - 9:00 AM
Keynote Address
9:00 AM - 10:00 AM
IC3 Glomerulopathy: A case-based review
-
How to handle infection and vaccination
-
The Pathway options: "Proximal or Central?"
-
The Transplant Timing: "Preemptive or Reactive?"
10:00 AM - 10:15 AM
Break
10:15 AM - 11:15 AM
How to Enroll in IgA Nephropathy (and other rare kidney diseases with newly approved drugs) Trials Today?
A roundtable discussion
-
Control arm,
-
historical controls,
-
registry data
11:15 AM - 11:35 AM
Break + Live Expert Interview in Poster Hall
11:15 AM - 12:05 PM
Oral Abstract Presentation
12:05 PM - 12:20 PM
Break
12:20 PM - 1:15 PM
Exhibitor Spotlight
Lunch Talk2:30 PM - 2:45 PM
Break
1:15 PM - 1:30 PM
Poster Presentations
1:30 PM - 2:30 PM
Apol1-mediated Kidney Disease: A case-based review
-
The "Second Hit" Mystery: "What Pulls the Trigger?"
-
The Inaxaplin Inflection Point
-
The Donor Dilemma: "To Test or Not to Test?"
-
G1 vs. G2: "Are the Alleles Created Equal?"
-
Genetic Equity and Access
2:30 PM - 2:45 PM
Break
2:45 PM - 3:45 PM
Trial Recruitment: An evidence-based approach to recruitment, retention, and adherence
A roundtable discussion
Management of Common Glomerulopathies During Pregnancy
3:45 PM - 4:45 PM
Break
4:00 PM - 5:00 PM
Helmut Rennke Endowed Lectureship
-
8:30 AM - 9:00 AM
Keynote Address
9:00 AM - 10:00 AM
Primary FSGS/MCD: A case-based review
-
The Nephrin Revolution: "Is a Biopsy Still Necessary?"
-
The Continuum Debate: "Is MCD Just 'Early' FSGS?"
-
The Post-Transplant "Recurrence" Mystery
-
How to handle maintenance
10:00 AM - 10:15 AM
Break
10:15 AM - 11:15 AM
Trial design in Primary FSGS: A roundtable discussion
-
Disease definitions
-
Eligibility Criteria
-
Endpoints
11:15 AM - 11:35 AM
Break + Live Expert Interview in Poster Hall
11:15 AM - 12:05 PM
Oral Abstract Presentation
12:05 PM - 12:20 PM
Break
12:20 PM - 1:15 PM
Exhibitor Spotlight
Lunch Talk2:30 PM - 2:45 PM
Break
1:15 PM - 1:30 PM
Poster Presentations
1:30 PM - 2:30 PM
Genetics of Kidney Disease: A lecture and panel discussion
-
An overview of genetic testing approaches
-
An overview of genetic kidney diseases
-
Genetic Impact by Disease Category
-
"Why are we missing 20% of cases?"
-
The VUS Dilemma: "What to do with the 'Maybe'?"
2:30 PM - 2:45 PM
Break
2:45 PM - 3:45 PM
Biomarker enrichment and AI in Trial Design
A roundtable discussion
Practical Approach to Complement Inhibitor Therapy
3:45 PM - 4:45 PM
Break
-
8:30 AM - 9:00 AM
Keynote Address
9:00 AM - 10:00 AM
Membranous Nephropathy: A case-based review
-
CTX vs RTX, and combined with CNI?
-
Antigen and antibody biology
-
Risk stratification and timing of treatment
-
Rituximab Resistance: "Why do 40% fail?"
-
Beyond PLA2R: "The Negative Patients"
-
The End of "Wait and See"
-
Plasma Cells and "Hard Remission"
-
Treatment Sequencing: "The STARMEN Hangover"
10:00 AM - 10:15 AM
Break
10:15 AM - 11:15 AM
Trial Design in Membranous Nephropathy: A roundtable discussion
-
PLA2R as an eligibility criterion and a surrogate endpoint
-
What to do with PLA2R-negative cases
11:15 AM - 11:35 AM
Break + Live Expert Interview in Poster Hall
11:15 AM - 12:05 PM
Oral Abstract Presentation
12:05 PM - 12:20 PM
Break
12:20 PM - 1:15 PM
Exhibitor Spotlight
Lunch Talk2:30 PM - 2:45 PM
Break
1:15 PM - 1:30 PM
Poster Presentations
1:30 PM - 2:30 PM
Paraprotein-mediated Kidney Disease: A case-based review
-
The "Invisible Clone" Dilemma: How do we treat a target we cannot see?
-
Complement vs. Clone: Which to Target? (In certain MGRS variants, such as C3 Glomerulopathy (C3G) or Thrombotic Microangiopathy (TMA) associated with a monoclonal protein, the paraprotein acts as a "trigger" for the complement system.)
-
High Relapse Rates Despite "Deep" Remissions
-
Risk Prediction
2:30 PM - 2:45 PM
Break
2:45 PM - 3:45 PM
Platforms and Baskets
A roundtable discussion
Pre-conception Counseling and Family Planning for Patients with GN
3:45 PM - 4:45 PM
Break
-
8:30 AM - 9:00 AM
Keynote Address
9:00 AM - 10:00 AM
ANCA Glomerulonephritis: A case-based review
-
The "Steroid-Free" Frontier: "Is Zero the New Standard?"
-
The PLEX Paradox: "Who Actually Needs Plasma Exchange?"
-
The Induction Combo: "Rituximab + Cyclophosphamide?"
-
The "Long-Haul" Maintenance: "When Do We Stop?"
-
The Molecular Definition of Remission
10:00 AM - 10:15 AM
Break
10:15 AM - 11:15 AM
The Outcasts: A roundtable discussion
How to answer pressing questions on those who are excluded from trials, such as RPGN, GFR<30, pediatrics, Class V LN
11:15 AM - 11:35 AM
Break + Live Expert Interview in Poster Hall
11:15 AM - 12:05 PM
Oral Abstract Presentation
12:05 PM - 12:20 PM
Break
12:20 PM - 1:15 PM
Exhibitor Spotlight
Lunch Talk2:30 PM - 2:45 PM
Break
1:15 PM - 1:30 PM
Poster Presentations
1:30 PM - 2:30 PM
Polycystic Kidney Disease: A case-based review
-
Diagnostic and prognostic criteria
-
Role of genetic testing
-
Treatment decision
2:30 PM - 2:45 PM
Break
2:45 PM - 3:45 PM
Patient Reported Outcomes
A roundtable discussion
Practical Approach to Genetic Testing
3:45 PM - 4:45 PM
Break
-
2026 Agenda
Abstract Submission
We are pleased accept abstract submissions for GlomCon Hawaii. This is a unique opportunity for researchers, clinicians, and trainees to showcase their work in the field of glomerular diseases and nephrology.
Top abstracts will be selected by the Educational Committee for either a poster or oral presentation during the conference. These sessions will highlight innovative research, original ideas, and impactful contributions to the advancement of nephrology.
Key Dates
Abstract Submission Opens: February 23, 2026
Submission Deadline: June 10, 2026
Notification of Acceptance: June 22, 2026
We invite you to submit your work and be part of this exciting scientific exchange. Click the button below to submit:
Travel Scholarship
The GlomCon Travel Scholarship is designed to support meeting attendees from low- to middle-income countries by providing financial assistance for travel and accommodation to attend GlomCon Hawaii 2026, taking place August 3-7, 2026, at Hyatt Regency, Maui.
To be considered for a travel scholarship, applicants must meet the following criteria:
-
Be a current or past GlomCon Fellow, GlomCon ILA Fellow, KPCP participant, or CEPR participant.
-
Reside and work in a low- or middle-income country as defined by the World Bank.
-
Demonstrate a strong interest in glomerular disease research, education, or clinical practice.
-
Commit to attending the full duration of the conference.
2026 Sponsors
We thank the following organizations for their generous support of GlomCon Hawai'i 2026.
Get in touch to inquire about sponsorship for GlomCon Hawaii 2026
Diamond Sponsors
Gold Sponsors
Bronze Sponsors
Non-profit Partners
Exhibitor
Silver Sponsors
